AR032208A1 - Composicion farmaceutica para uso topico a base de corticosteroides para el tratamiento de la fimosis - Google Patents

Composicion farmaceutica para uso topico a base de corticosteroides para el tratamiento de la fimosis

Info

Publication number
AR032208A1
AR032208A1 ARP010106081A ARP010106081A AR032208A1 AR 032208 A1 AR032208 A1 AR 032208A1 AR P010106081 A ARP010106081 A AR P010106081A AR P010106081 A ARP010106081 A AR P010106081A AR 032208 A1 AR032208 A1 AR 032208A1
Authority
AR
Argentina
Prior art keywords
corticosteroids
treatment
pharmaceutical composition
use based
phymosis
Prior art date
Application number
ARP010106081A
Other languages
English (en)
Spanish (es)
Original Assignee
Apsen Farmaceutica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apsen Farmaceutica S A filed Critical Apsen Farmaceutica S A
Publication of AR032208A1 publication Critical patent/AR032208A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP010106081A 2000-12-28 2001-12-27 Composicion farmaceutica para uso topico a base de corticosteroides para el tratamiento de la fimosis AR032208A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0006556-0A BR0006556A (pt) 2000-12-28 2000-12-28 Composição farmacêutica para uso tópico à base de corticosteróide para tratamento de fimose

Publications (1)

Publication Number Publication Date
AR032208A1 true AR032208A1 (es) 2003-10-29

Family

ID=36686652

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010106081A AR032208A1 (es) 2000-12-28 2001-12-27 Composicion farmaceutica para uso topico a base de corticosteroides para el tratamiento de la fimosis

Country Status (12)

Country Link
US (1) US7666858B2 (enExample)
EP (1) EP1365766B1 (enExample)
JP (1) JP5095907B2 (enExample)
CN (1) CN1270719C (enExample)
AR (1) AR032208A1 (enExample)
AU (1) AU2002221365A1 (enExample)
BR (1) BR0006556A (enExample)
DE (1) DE60121047T2 (enExample)
ES (1) ES2267671T3 (enExample)
MX (1) MXPA03005813A (enExample)
RU (1) RU2279893C2 (enExample)
WO (1) WO2002053137A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070134232A1 (en) * 2005-12-14 2007-06-14 Joel Studin Topical bite care composition
US20070225670A1 (en) * 2006-03-14 2007-09-27 Connell Thomas J Diapers for improving male genital health and methods of using the same
JP2010519211A (ja) * 2007-02-15 2010-06-03 アラーガン、インコーポレイテッド 膀胱もしくは前立腺障害または多汗症を処置するためのボツリヌス毒素および酵素の使用
CN102933233A (zh) * 2010-06-17 2013-02-13 日东电工株式会社 肾纤维化处理剂
MX348420B (es) 2010-07-20 2017-06-12 Halozyme Inc Efectos secundarios adversos asociados con la administracion de agentes anti-hialuronano y metodos para mejorar o prevenir los efectos secundarios.
CN102302779A (zh) * 2011-07-29 2012-01-04 岳中瑾 治疗包茎的乳膏制剂及其应用
RU2569431C2 (ru) * 2013-07-08 2015-11-27 Александр Васильевич Газаматов Способ консервативного лечения фимоза
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN110314168A (zh) * 2019-07-27 2019-10-11 清远市人民医院 一种用于治疗小儿包茎的药物组合物及其制备方法
RU2730476C1 (ru) * 2019-12-24 2020-08-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Противовоспалительная мазь для животных

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2058780C1 (ru) * 1992-11-17 1996-04-27 Совместное русско-американское акционерное общество закрытого типа "Неофарм" Средство, обладающее тонизирующим действием на гладкую мускулатуру вен, мочевого пузыря и предстательной железы

Also Published As

Publication number Publication date
BR0006556A (pt) 2002-09-17
ES2267671T3 (es) 2007-03-16
DE60121047T2 (de) 2007-06-21
MXPA03005813A (es) 2005-02-14
EP1365766A2 (en) 2003-12-03
CN1270719C (zh) 2006-08-23
US7666858B2 (en) 2010-02-23
RU2279893C2 (ru) 2006-07-20
WO2002053137A3 (en) 2003-04-24
JP5095907B2 (ja) 2012-12-12
EP1365766B1 (en) 2006-06-21
US20040067922A1 (en) 2004-04-08
DE60121047D1 (de) 2006-08-03
WO2002053137A2 (en) 2002-07-11
RU2003119439A (ru) 2005-02-27
HK1060850A1 (en) 2004-08-27
CN1487833A (zh) 2004-04-07
AU2002221365A1 (en) 2002-07-16
JP2004519451A (ja) 2004-07-02

Similar Documents

Publication Publication Date Title
ES2162517T3 (es) Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia.
DK0969813T3 (da) Topisk farmaceutisk sammensætning omfattende et kolinergt middel eller et calciumkanalblokerende middel
DE60105448D1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
NO20022292D0 (no) Nye topiske östradiolprogesteronpreparater med systemisk effekt
BR0109779A (pt) Soluções moleculares hidrofìlicas dispersas de carvedilol
ECSP045520A (es) Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos
NO20024309D0 (no) Intradermal penetreringsmidler for topikal lokal anestetisk administrering
AR063201A1 (es) Composiciones farmaceuticas de ropinirol y metodos de uso de las mismas
ES2190472T3 (es) Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno.
AR033342A1 (es) Una composicion otica topica o intranasal para tratar el dolor otico y el uso topico de agonistas de opioides kapa para tratar el dolor otico
MX9700534A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para tratar las enfermedades de prostata, endometriosis y obesidad.
AR062775A1 (es) Composicion farmaceutica capaz de mejorar la actividad de glp -1 en un ser humano y su uso para preparar un medicamento
PE20040068A1 (es) Decanoato, undecanoato y dodecanoato de etonogestrel
BRPI0416275A (pt) métodos de tratar, controlar ou prevenir um cáncer especìfico e uma doença associada com angiogênese indesejada
ATE382356T1 (de) Pharmazeutische zusammensetzung enthaltend estetrolderivate und anwendung in der krebsbehandlung
ES2171589T3 (es) Composiciones farmaceuticas solidas anhidras para uso vaginal.
TR200201071T2 (tr) Rar selektif retinoid antagonistleri kullanılarak anfizem tedavisi
ES2103493T3 (es) Uso de parathormona, de sus fragmentos biologicamente activos y de peptidos relacionados para el tratamiento del embarazo.
BR0006556A (pt) Composição farmacêutica para uso tópico à base de corticosteróide para tratamento de fimose
ES2181710T3 (es) Adenovirus recombinantes y su utilizacion en terapia genica para el tratamiento de las patologias oculares.
AR051765A1 (es) Compuestos de moleculas conjugadas con una actividad reforzada de absorcion de celulas
ES2174533T3 (es) Uso de una mezcla de un diol y un acido alfa-hidroxi para el tratamiento de enfermedades de la piel hiperqueratoticas.
ES2165948T3 (es) Modificacion cristalina termoestable y apta para almacenaje de n-metil-n-((1s)-1-fenil-2-((3s)-3-hidroxi-pirrolidin-1-il)-etil)-2,2-difenil-acetamida, y procedimiento para su obtencion.
PE20050665A1 (es) ESTROGENOS SELECTIVOS DE 8ß-VINIL-ESTRA-1,3,5(10)-TRIEN-3,17ß-DIOL Y 17ß-FLUOR-9-VINIL-ESTRA-1,3,6(10)-TRIEN-3,16ALFA-DIOL
CL2002001701A1 (es) Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno.

Legal Events

Date Code Title Description
FB Suspension of granting procedure